Thiazolidinediones: Do harms outweigh benefits?

被引：19

作者：

Lipscombe, Lorraine L. ^{[1
,2
]}

机构：

[1] Univ Toronto, Inst Clin Evaluat Sci, Dept Med, Toronto, ON M4N 3M5, Canada

[2] Womens Coll Hosp, Toronto, ON M5S 1B2, Canada

来源：

CANADIAN MEDICAL ASSOCIATION JOURNAL | 2009年 / 180卷 / 01期

关键词：

CARDIOVASCULAR EVENTS; METAANALYSIS; RISK; ROSIGLITAZONE; PIOGLITAZONE; TRIALS; DEATH;

D O I：

10.1503/cmaj.081713

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

页码：16 / 17

页数：2

共 9 条

[1]

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial [J].

Dormandy, JA ;

Charbonnel, B ;

Eckland, DJA ;

Erdmann, E ;

Massi-Benedetti, M ;

Kmoules, IK ;

Skene, AM ;

Tan, MH ;

Lefébvre, PJ ;

Murray, GD ;

Standl, E ;

Wilcox, RG ;

Wlhelmsen, L ;

Betteridge, J ;

Birkeland, K ;

Golay, A ;

Heine, RJ ;

Korányi, L ;

Laakso, M ;

Mokán, M ;

Norkus, A ;

Pirags, V ;

Podar, T ;

Scheen, A ;

Scherbaum, W ;

Schernthaner, G ;

Schmitz, O ;

Skrha, J ;

Smith, U ;

Taton, J .

LANCET, 2005, 366 (9493) :1279-1289

[2]

Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials [J].

Lago, Rodrigo M. ;

Singh, Premranjan P. ;

Nesto, Richard W. .

LANCET, 2007, 370 (9593) :1129-1136

[3]

Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus - A meta-analysis of randomized trials [J].

Lincoff, A. Michael ;

Wolski, Kathy ;

Nicholls, Stephen J. ;

Nissen, Steven E. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (10) :1180-1188

[4]

Thiazolidinediones and cardiovascular outcomes in older patients with diabetes [J].

Lipscombe, Lorraine L. ;

Gomes, Tara ;

Levesque, Linda E. ;

Hux, Janet E. ;

Juurlink, David N. ;

Alter, David A. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (22) :2634-2643

[5]

Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis [J].

Loke, Yoon K. ;

Singh, Sonal ;

Furberg, Curt D. .

CANADIAN MEDICAL ASSOCIATION JOURNAL, 2009, 180 (01) :32-39

[6]

Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes (vol 356, pg 2457, 2007) [J].

Nissen, Steven E. ;

Wolski, Kathy .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (24) :2457-2471

[7]

Long-term risk of cardiovascular events with rosiglitazone - A meta-analysis [J].

Singh, Sonal ;

Loke, Yoon K. ;

Furberg, Curt D. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (10) :1189-1195

[8]

US Food and Drug Administration, 2018, FDA BRIEF DOC JOINT

[9]

Drug therapy: Thiazolidinediones [J].

Yki-Jarvinen, H .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (11) :1106-1118

← 1 →